[
  {
    "ts": null,
    "headline": "AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names",
    "summary": "Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, June 4, 2025 /PRNewswire/ -- Equity Insider News Commentary – Generative AI is transforming healthcare...",
    "url": "https://finnhub.io/api/news?id=24565b2fe2ce4d114188dceae9100d7a9a4104d7836d135e96b8c498ae3bc5df",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749047825,
      "headline": "AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names",
      "id": 135013666,
      "image": "",
      "related": "ORCL",
      "source": "Finnhub",
      "summary": "Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, June 4, 2025 /PRNewswire/ -- Equity Insider News Commentary – Generative AI is transforming healthcare...",
      "url": "https://finnhub.io/api/news?id=24565b2fe2ce4d114188dceae9100d7a9a4104d7836d135e96b8c498ae3bc5df"
    }
  },
  {
    "ts": null,
    "headline": "First Eagle U.S. Value Fund Q1 2025 Commentary",
    "summary": "U.S. Fund A Shares (without sales charge*) posted a return of 4.06% in first quarter 2025. Read more here.",
    "url": "https://finnhub.io/api/news?id=d61feddee971dc4678d5c6138e84ad1adc61ec75f562ab4edb0636d1d2c7e577",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749045600,
      "headline": "First Eagle U.S. Value Fund Q1 2025 Commentary",
      "id": 135013400,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478156131/image_1478156131.jpg?io=getty-c-w1536",
      "related": "ORCL",
      "source": "SeekingAlpha",
      "summary": "U.S. Fund A Shares (without sales charge*) posted a return of 4.06% in first quarter 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=d61feddee971dc4678d5c6138e84ad1adc61ec75f562ab4edb0636d1d2c7e577"
    }
  },
  {
    "ts": null,
    "headline": "Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle",
    "summary": "Investing.com -- Mizuho has updated its U.S. Top Picks list for June, adding CVS Health (NYSE:CVS), PayPal (NASDAQ:PYPL) and Oracle (NYSE:ORCL) to its highest-conviction ideas, alongside ConocoPhillips (NYSE:COP), First Solar (NASDAQ:FSLR), Insmed (NASDAQ:INSM), Corteva (NYSE:CTVA), and Carrier Global (NYSE:CARR).",
    "url": "https://finnhub.io/api/news?id=5b7c5067efdfcf52425480c41829a605f593a3065da7c19c83e195128857bfd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749040301,
      "headline": "Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle",
      "id": 135009790,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ORCL",
      "source": "Yahoo",
      "summary": "Investing.com -- Mizuho has updated its U.S. Top Picks list for June, adding CVS Health (NYSE:CVS), PayPal (NASDAQ:PYPL) and Oracle (NYSE:ORCL) to its highest-conviction ideas, alongside ConocoPhillips (NYSE:COP), First Solar (NASDAQ:FSLR), Insmed (NASDAQ:INSM), Corteva (NYSE:CTVA), and Carrier Global (NYSE:CARR).",
      "url": "https://finnhub.io/api/news?id=5b7c5067efdfcf52425480c41829a605f593a3065da7c19c83e195128857bfd0"
    }
  },
  {
    "ts": null,
    "headline": "Oracle Enables Automation of Drug Supply Management Across Vendors and Studies to Help Speed and Simplify Clinical Trials",
    "summary": "New interoperability advancements in Oracle's enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. This aids in reducing inefficiencies and waste, and accelerating trial",
    "url": "https://finnhub.io/api/news?id=11bd3547514ca07f80195ae586ee0bd07a57d151f1f797a4061e2feea5722199",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749038400,
      "headline": "Oracle Enables Automation of Drug Supply Management Across Vendors and Studies to Help Speed and Simplify Clinical Trials",
      "id": 135009791,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ORCL",
      "source": "Yahoo",
      "summary": "New interoperability advancements in Oracle's enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. This aids in reducing inefficiencies and waste, and accelerating trial",
      "url": "https://finnhub.io/api/news?id=11bd3547514ca07f80195ae586ee0bd07a57d151f1f797a4061e2feea5722199"
    }
  },
  {
    "ts": null,
    "headline": "First Eagle Global Fund Q1 2025 Commentary",
    "summary": "Global Fund A Shares (without sales charge*) posted a return of 6.92% in first quarter 2025. Developed Europe and North America were the leading contributors.",
    "url": "https://finnhub.io/api/news?id=19ba91e2cb2c80159226ce411b60b9f5bb237ddbf05e53d6c7932073491e3b93",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749037800,
      "headline": "First Eagle Global Fund Q1 2025 Commentary",
      "id": 135010808,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1349695390/image_1349695390.jpg?io=getty-c-w1536",
      "related": "ORCL",
      "source": "SeekingAlpha",
      "summary": "Global Fund A Shares (without sales charge*) posted a return of 6.92% in first quarter 2025. Developed Europe and North America were the leading contributors.",
      "url": "https://finnhub.io/api/news?id=19ba91e2cb2c80159226ce411b60b9f5bb237ddbf05e53d6c7932073491e3b93"
    }
  }
]